Research Triangle Park, NC . March 19, 2009. Mi-Co announced today a strategic alliance with Code Refinery, a provider of FDA-compliant software and services, to jointly deliver custom software and data collection solutions for pharmaceutical, biotech and medical device customers. By working together, Mi-Co and Code Refinery will be able to offer their customers a broader range of software solutions and services and deliver additional return on investment.
Mi-Co provides point of contact data collection solutions with a pen-based, paper-like interface which extend and optimize EDC systems used in clinical studies, as well as for other form-based data collection needs in clinical research. Mi-Co’s technology, Mi-Forms, is available for Tablet PC, UltraMobile PC and Digital Pen. Benefits include elimination of manual keying of data from paper forms, rapid availability of data for reporting and analysis, and minimal user training.
Code Refinery is focused on software development, testing and validation to bring medical device, clinical diagnostic products and solutions to market. Code Refinery gives customers Complete Confidence in their medical and device software, Peace Of Mind that it will meet the highest standards for real-world operation and FDA compliance and Tangible Results to successfully bring their product or solution to market and maintain compliance. High-quality Code Refinery solutions allow customers to save time and money in getting their products to the marketplace.
“The combination of high-quality software and services from an experienced solution provider like Code Refinery, with Mi-Co’s market-leading handwriting recognition and data collection technology, will provide strong value-add for organizations looking for FDA-compliant software solutions. Mi-Co is very pleased to partner with them, “stated Mi-Co CEO Greg Clary.
“Mi-Co’s technology, Mi-Forms, can greatly streamline customer data collection processes. There is huge potential with pharmaceutical, biotech and medical device customers to save time, money and increase quality of critical data collection processes including development and validation of medical device software requiring FDA compliance,” said Samir Dandekar, Partner and Director of Business Development for Code Refinery.
About Code Refinery:
Since 1997, we have helped industry leaders who produce systems used in clinical diagnostics, healthcare, medical devices and manufacturing regulated by the FDA. Code Refinery is dedicated to helping our clients design, develop and ensure the accuracy and compliance of software that performs in vital applications. For more information on Code Refinery, please visit http://code-refinery.com.
Since 1999, Mi-Co has been providing market-leading data collection and process automation solutions to a wide variety of industries including hospital, home health, clinical research and clinical trials. The Mi-Forms technology has been validated for FDA 21 CFR Part 11 compliance and is CDISC and CDASH compatible. For more information on Mi-Co, please visit www.beyondedc.com and www.mi-corporation.com.